OncoTargets and Therapy

Artificial Intelligence and Multi-Omics in Precision Oncology: From Biomarker Discovery to Translational Therapeutics

Head and neck cancers encompass one of the most biologically diverse and clinically challenging groups of malignancies in oncology. From HPV-driven squamous cell carcinomas to rare salivary gland and thyroid tumors, advances in molecular biology, imaging, systemic therapy, radiation techniques, and survivorship care are rapidly reshaping the field. However, meaningful insights often arise not only from large, randomized trials, but also from carefully described case series, real-world experiences, translational observations, and authoritative reviews, particularly in rare diseases where prospective data remain limited.
This Article Collection aims to provide a comprehensive, inclusive, and forward-looking platform that captures innovation across the entire spectrum of head and neck oncology—bridging common and rare tumors, bench and bedside, and efficacy with quality of life.